MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
National Research Corporation ROCE Ratio 2011-2026 | NRC
Annual ROCE Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161.47 | 112.5 | 81.8 | 64.61 | 58.91 | 66.36 | 59.33 | 57.9 | 36.02 | 35.01 | 31.14 | 27.85 | 28.41 | - | - | 28.52 | 31.01 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 161.47 | 27.85 | 58.72 |
Quarterly ROCE Ratio National Research Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131.74 | 113.52 | 81.52 | 97.78 | 68.81 | 86.01 | 75.01 | 65.03 | 41.32 | 57.72 | 57.27 | 59.58 | 47.5 | 63.3 | 62.94 | 62.6 | 48.24 | 66.93 | 65.55 | 66.93 | 50.52 | 81.59 | 93.75 | 111.87 | 94.47 | 142.5 | 152.07 | 168.16 | 135.62 | 143.53 | 104.88 | 75.33 | 28.38 | 37.25 | 37.81 | 38.09 | 27.01 | 35.83 | 35.54 | 34.92 | 25.25 | 33.41 | 31.79 | 32.79 | 24.93 | 33.33 | 32.89 | 35.75 | 26.17 | 36.12 | 36.91 | 39.92 | 29.86 | 37.41 | 34.36 | 35.42 | 24.71 | 7.55 | 6.9 | 10.26 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 168.16 | 6.9 | 60.4 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.96 | 5.63 % | $ 483 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.76 | 1.09 % | $ 177 M |  China |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 19.83 | 3.07 % | $ 575 M | USA |
 |
Agilent Technologies
A
|
25.0 | $ 115.62 | -2.55 % | $ 35.1 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 21.82 | 1.77 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 93.06 | 2.26 % | $ 6.28 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 424.0 | -1.1 % | $ 12.2 B | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 2.53 | 31.09 % | $ 3.37 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.29 | 4.89 % | $ 397 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.96 | -1.21 % | $ 1.15 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
-76.66 | $ 194.24 | -11.64 % | $ 19.1 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 177.62 | -2.23 % | $ 8.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 27.21 | 0.18 % | $ 25.8 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
-33.71 | $ 5.98 | -0.17 % | $ 534 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 95.7 | 3.73 % | $ 12 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 5.03 | -6.16 % | $ 210 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.95 | - | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 124.49 | -0.41 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
-35.1 | $ 141.88 | 2.29 % | $ 22.6 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.95 | -2.5 % | $ 8.63 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.61 | 2.52 % | $ 219 M | Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 56.85 | -2.89 % | $ 3.4 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.15 | -2.05 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 465.0 | -1.99 % | $ 175 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 254.12 | -1.52 % | $ 21.1 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 131.06 | 0.27 % | $ 6.13 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
7.05 | $ 355.13 | 1.32 % | $ 21.1 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.05 | -2.16 % | $ 1.96 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 187.39 | -1.82 % | $ 20.8 B | USA |